【摘要】：目的探討前列腺癌骨轉移的臨床特點及其危險因素。方法回顧性分析2006年6月-2016年6月南昌大學第一附屬醫(yī)院收治的、經穿刺活檢或術后病理檢查確診為前列腺癌患者的臨床資料,記錄首次入院時的一般資料、化驗檢查結果及病理切片Gleason評分,分析各臨床因素與骨轉移發(fā)生的關系,明確骨轉移發(fā)生的相關危險因素。結果共納入585例前列腺癌患者,其中發(fā)生骨轉移228例,無骨轉移357例。在骨轉移患者中,骨盆轉移發(fā)生率最高,占81.58%,其次是脊柱轉移(63.16%)和肋骨轉移(58.33%),鎖骨轉移最少(14.47%)。Logistic回歸分析顯示年齡71.5歲、堿性磷酸酶(ALP)85.5U/L、前列腺特異性抗原(PSA)79.88μg/L和Gleason評分7.5分是前列腺癌骨轉移的危險因素。ROC曲線分析顯示,上述各因素診斷骨轉移的靈敏度分別為56.1%、66.7%、68.4%、56.1%,特異度分別為56.6%、81.8%、70.0%、65.3%。結論前列腺癌骨轉移以骨盆轉移最為多見,年齡、ALP、PSA及Gleason評分是前列腺癌發(fā)生骨轉移的危險因素。
[Abstract]:Objective to investigate the clinical features and risk factors of bone metastasis in prostate cancer. Methods the clinical data of patients with prostate cancer diagnosed by puncture biopsy or postoperative pathological examination in the first affiliated Hospital of Nanchang University from June 2006 to June 2016 were analyzed retrospectively, and the general data of the first admission were recorded. The relationship between clinical factors and bone metastasis was analyzed, and the related risk factors of bone metastasis were identified. Results there were 585 cases of prostate cancer including 228 cases of bone metastasis and 357 cases of no bone metastasis. The incidence of pelvic metastasis was the highest (81.58%), followed by spinal metastasis (63.16%) and rib metastasis (58.33%), and clavicle metastasis was the least (14.47%) by). Logistic regression analysis. Alkaline phosphatase (ALP) 85.5 U / L, prostate specific antigen (PSA) 79.88 渭 g / L and Gleason score 7.5 were risk factors for bone metastasis of prostate cancer. The sensitivity of the above factors in the diagnosis of bone metastasis was 56.1 and 68.7, and the specificity was 56.6 and 81.8, respectively. Conclusion pelvic metastasis is the most common bone metastasis in prostate cancer. Age, ALP,PSA and Gleason scores are the risk factors for bone metastasis of prostate cancer.
【作者單位】： 南昌大學第一附屬醫(yī)院骨科;
【基金】：江西省主要學科帶頭人資助計劃(20162BCB22022) 江西省杰出青年人才資助計劃(20162BCB23057)~~
【分類號】：R737.25

【相似文獻】

相關期刊論文 前10條

1 張星霖;張盛;;唑來磷酸治療骨轉移癌癥痛的療效觀察[J];中國疼痛醫(yī)學雜志;2006年02期

2 肖必文;乳腺癌術后骨轉移臨床分析[J];實用腫瘤雜志;2001年04期

3 黃劍,肖春容;以骨轉移為首發(fā)表現的肺癌2例[J];四川醫(yī)學;2002年02期

4 陳麗敏;鄭弘宇;黃偉煒;;乳腺癌術后骨轉移的相關因素分析[J];福建醫(yī)藥雜志;2006年03期

5 ;2010年揚帆計劃,為更多骨轉移患者帶來福音(英文)[J];Chinese-German Journal of Clinical Oncology;2010年08期

6 劉云峰;;常規(guī)放療和低分割放療治療骨轉移止痛28例的效果分析[J];求醫(yī)問藥(下半月);2012年02期

7 樊英;丁曉燕;馬飛;袁們;張頻;王佳玉;李青;徐兵河;;三陰性乳腺癌首發(fā)骨轉移患者的臨床特征、治療及預后分析[J];中華臨床醫(yī)師雜志(電子版);2012年19期

8 申葉珍;孫文湘;賈曉s，

本文編號：2330463